Pyoderma Gangrenosum Overview

Save information for later
Sign Up

Learn About Pyoderma Gangrenosum

What is the definition of Pyoderma Gangrenosum?
Pyoderma gangrenosum is a rare, destructive inflammatory skin disease of which a painful nodule or pustule breaks down to form a progressively enlarging ulcer. Lesions may occur either in the absence of any apparent underlying disorder or in association with other diseases, such as ulcerative colitis, Crohn's disease, polyarthritis (an inflammation of several joints together), gammopathy, vasculitis, leukemia, and other conditions. Each year in the United States, Pyoderma gangrenosum occurs in about 1 person per 100,000 people. Pyoderma gangrenosum belongs to a group of autoinflammatory skin diseases called neutrophilic dermatoses. Neutrophils are a type of white blood cell or leukocyte which form an early line of defense against bacterial infections. Ulcerations associated with Pyoderma gangrenosum may occur after trauma or injury to the skin, a process called pathergy.
What are the alternative names for Pyoderma Gangrenosum?
  • Pyoderma gangrenosum
Who are the top Pyoderma Gangrenosum Local Doctors?
Advanced in Pyoderma Gangrenosum
Dr. Bounthavy Homsombath
General Surgery | Plastic Surgery
Advanced in Pyoderma Gangrenosum
Dr. Bounthavy Homsombath
General Surgery | Plastic Surgery

Joseph M Still Burn Centers, Inc

3651 Wheeler Rd, 
Augusta, GA 
 (4.0 mi)
706-863-9595
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Bounthavy Homsombath is a General Surgeon and a Plastic Surgeon in Augusta, Georgia. Dr. Homsombath and is rated as an Advanced provider by MediFind in the treatment of Pyoderma Gangrenosum. His top areas of expertise are Necrotizing Fasciitis, Cellulitis, Necrosis, Tissue Biopsy, and Gastrostomy. Dr. Homsombath is currently accepting new patients.

Experienced in Pyoderma Gangrenosum
Dr. Jon C. Gibbs
Internal Medicine
Experienced in Pyoderma Gangrenosum
Dr. Jon C. Gibbs
Internal Medicine

Hospital Medicine Consulting LLC

1537 Walton Way, 
Augusta, GA 
 (2.3 mi)
706-731-1200
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Jon Gibbs is an Internal Medicine provider in Augusta, Georgia. Dr. Gibbs and is rated as an Experienced provider by MediFind in the treatment of Pyoderma Gangrenosum. His top areas of expertise are Cellulitis, Necrotizing Fasciitis, Necrosis, Infective Endocarditis, and Gastrostomy. Dr. Gibbs is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Pyoderma Gangrenosum
Dr. Martin K. Hardy
General Surgery
Experienced in Pyoderma Gangrenosum
Dr. Martin K. Hardy
General Surgery

Joseph M Still Burn Centers, Inc

3675 J Dewey Gray Cir, 
Augusta, GA 
 (3.9 mi)
706-863-9595
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

Martin Hardy is a General Surgeon in Augusta, Georgia. Dr. Hardy and is rated as an Experienced provider by MediFind in the treatment of Pyoderma Gangrenosum. His top areas of expertise are Necrotizing Fasciitis, Peptic Ulcer, Necrosis, Tissue Biopsy, and Gastrostomy. Dr. Hardy is currently accepting new patients.

View All Doctors
What are the latest Pyoderma Gangrenosum Clinical Trials?
A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy
A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: The purpose of this study is to find out whether a medicine called spesolimab helps people with pyoderma gangrenosum (PG). The main aim is to see whether spesolimab leads to closure of PG ulcers. This study is open to adults with ulcerative PG with at least 1 ulcer that measures between 5 cm\^2 to 80 cm\^2 in size. This study has 2 parts. In Part 1, participants are put into groups randomly, which...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-blind, Placebo-controlled, Multicenter, Adaptive Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in the Treatment of Ulcerative Pyoderma Gangrenosum
A Randomized, Double-blind, Placebo-controlled, Multicenter, Adaptive Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in the Treatment of Ulcerative Pyoderma Gangrenosum
Enrollment Status: Recruiting
Publish Date: December 20, 2024
Intervention Type: Drug
Study Phase: Phase 3

Summary: A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate efficacy and safety of vilobelimab in the treatment of ulcerative pyoderma gangrenosum

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center